Fant 10007 publikasjoner. Viser side 114 av 401:
2015
2014
Polychlorinated biphenyls (PCBs) can be used as chemical sentinels for the assessment of anthropogenic influences on Arctic environmental change. We present an overview of studies on PCBs in the Arctic and combine these with the findings from ArcRisk—a major European Union-funded project aimed at examining the effects of climate change on the transport of contaminants to and their behaviour of in the Arctic—to provide a case study on the behaviour and impact of PCBs over time in the Arctic. PCBs in the Arctic have shown declining trends in the environment over the last few decades. Atmospheric long-range transport from secondary and primary sources is the major input of PCBs to the Arctic region. Modelling of the atmospheric PCB composition and behaviour showed some increases in environmental concentrations in a warmerArctic, but the general decline in
PCB levels is still the most prominent feature. ‘Within-Arctic’ processing of PCBs will be affected by climate change-related processes such as changing wet deposition. These in turn will influence biological exposure and uptake of PCBs. The pan-Arctic rivers draining large Arctic/sub-Arctic catchments provide a significant source of PCBs to the Arctic Ocean, although changes in hydrology/sediment transport combined with a changing marine environment remain areas of uncertainty with regard to PCB fate. Indirect effects of climate change on human exposure, such as a changing diet will influence and possibly reduce PCB
exposure for indigenous peoples. Body burdens of PCBs have declined since the 1980s and are predicted to decline further.
2018
2002
2015
Polychlorinated n-alkanes (PCAs) are the main components of chlorinated paraffins (CPs) mixtures, that have been commonly grouped into short-chain (SCCPs, C10–13), medium-chain (MCCPs, C14–17), and long-chain (LCCPs, C18-30) CPs. PCAs pose a significant risk to human health as they are broadly present in indoor environments and are potentially persistent, bioaccumulative, and toxic. The lack of specific terminology and harmonization in analytical methodologies for PCA analysis complicates direct comparisons between studies. The present work summarizes the different methodologies applied for the analysis of PCAs in indoor dust, air, and organic films. The large variability between the reviewed studies points to the difficulties to assess PCA contamination in these matrices and to mitigate risks associated with indoor exposure. Based on our review of physicochemical properties of PCAs and previously reported sum of measurable S/M/LCCPs levels, the homologue groups PCAs–C10–13 are found to be mostly present in the gas phase, PCAs–C14–17 in particulate matter and organic films, and PCAs–C≥18 in settled dust. However, we emphasized that mapping PCA sources and distribution in the indoors is highly dependent on the individual homologues. To further comprehend indoor PCA distribution, we described the uses of PCA in building materials and household products to apportion important indoor sources of emissions and pathways for human exposure. The greatest risk for indoor PCAs were estimated to arise from dermal absorption and ingestion through contact with dust and CP containing products. In addition, there are several factors affecting indoor PCA levels and exposure in different regions, including legislation, presence of specific products, cleaning routines, and ventilation frequency. This review provides comprehensive analysis of available indoor PCA data, the physicochemical properties, applied analytical methods, possible interior sources, variables affecting the levels, human exposure to PCAs, as well as need for more information, thereby providing perspectives for future research studies.
2024
2002
2001
Background Previous studies have reported associations between certain persistent organic pollutants (POPs) and type 2 diabetes mellitus (T2DM). Polybrominated diphenyl ethers (PBDEs) are a class of POPs that are found in increasing concentrations in humans. Although obesity is a known risk factor for T2DM and PBDEs are fat-soluble, very few studies have investigated associations between PBDEs and T2DM. No longitudinal studies have assessed associations between repeated measurements of PBDE and T2DM in the same individuals and compared time trends of PBDEs in T2DM cases and controls. Objectives To investigate associations between pre- and post-diagnostic measurements of PBDEs and T2DM and to compare time trends of PBDEs in T2DM cases and controls. Methods Questionnaire data and serum samples from participants in the Tromsø Study were used to conduct a longitudinal nested case-control study among 116 T2DM cases and 139 controls. All included study participants had three pre-diagnostic blood samples (collected before T2DM diagnosis in cases), and up to two post-diagnostic samples after T2DM diagnosis. We used logistic regression models to investigate pre- and post-diagnostic associations between PBDEs and T2DM, and linear mixed-effect models to assess time trends of PBDEs in T2DM cases and controls. Results We observed no substantial pre- or post-diagnostic associations between any of the PBDEs and T2DM, except for BDE-154 at one of the post-diagnostic time-points (OR = 1.65, 95% CI: 1.00, 2.71). The overall time trends of PBDE concentrations were similar for cases and controls. Discussion The study did not support PBDEs increasing the odds of T2DM, prior to or after T2DM diagnosis. T2DM status did not influence the time trends of PBDE concentrations.
2023
2006
2020
2021
2023
2011
2010